欧洲疫苗接种设备市场 – 行业趋势和 2030 年预测

欧洲疫苗接种设备市场分析和规模

糖尿病患者在世界范围内变得越来越普遍。全球对 COVID-19 疫苗的需求提供了巨大的增长机会，极大地帮助了该行业。疫苗开发研究和投资的增加也是市场的主要驱动力之一。寻找和监督 COVID-19 疫苗的紧迫性引起了人们对提供有效和安全的病毒递送系统（最好是多种递送系统）的兴趣。

Data Bridge Market Research 分析了 2023-2030 年预测期内疫苗接种设备市场的增长率。在上述预测期内，疫苗接种设备市场的预期复合年增长率趋于 8% 左右。2022 年市场价值为 9.2668 亿美元，到 2030 年将增长至 17.1522 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

欧洲疫苗接种设备市场范围和细分

市场定义

疫苗接种是一种通过不同方式接种疫苗的过程，有助于预防相关疾病。疫苗是一组生物制剂，用于对抗人类病毒和细菌相关感染。疫苗种类包括灭活/灭活疫苗、活/减毒疫苗、类毒素疫苗和结合疫苗。使用注射器或针头，疫苗可通过肌肉内或皮下注射。

欧洲疫苗接种设备市场动态

驱动程序

• 市场参与者的战略发展不断加强

Different market players are engaged in strategic activities such as mergers and acquisitions to increase the availability of products in the market. For instance, the next-generation glass pre-fillable syringe (PFS) named BD Effivax was launched by Becton, Dickin, son, and Company in 2022. The Company sets a new standard for performance for vaccine PFS with new criteria for cosmetics, contamination, processability, and integrity. Thus, this factor increases the growth of the market.  

• Increasing R&D Activities

Growing research and investment in the development of vaccines is also one of the major drivers of the market. The Canadian Institutes of Health Research Institute of Infection and Immunity supports and funds research activities aimed at decreasing the burden of allergies, infectious diseases, and immune-mediated diseases. The institute invests about USD 1 million every year to support the research of hepatitis C, USD 45.7 million through partnerships for pandemic influenza research, and USD 22.5 million to support the CIHR HIV/AIDS Research Initiative. Thus, this boosts the market growth.

Opportunities

• Growing Demand of Auto-Disable (AD) Syringes

The increasing demand of auto-disable (AD) syringes boost the demand of the market. WHO recommends the usage of auto-disable (AD) syringes for the immunization program as they are made to prevent re-use as AD syringes lock automatically after a single use. Additionally, AD syringes provide the assurance that vaccinations are administered safely and without chances of contamination. Thus, this factor boost the growth of the market.  

• Increasing Rate of Product Launches

There are increasing number of product launches associated with vaccines that are helpful in surging the market growth. For instance, vaccines developed by the Serum Institute of India acquired a 50% share in a pharma packing firm, Schott Kaisha in 2021. This initiative positions the Serum Institute of India in a joint venture with Schott AG which is a specialty glass company based in Germany. Moreover, numerous initiatives taken by government agencies to develop new vaccines offer opportunities for growth in the market. Thus, this factor increases the market growth.

Restraints/Challenges

• Complications Associated with Vaccine Administration Devices

There are various complications associated with vaccine administration devices that impede the market growth. Effects such as fussiness, loss of appetite,  fever, feeling tired, and vomiting. There are more serious reactions, such as consistent crying for 3 hours or more, seizures, high fever (over 105°F) after DTaP vaccination. These all factors hamper the growth of the market.

This vaccine administration devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine administration devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2020, Enesi Pharma has been shortlisted for its best vaccine platform IMPLAVAX solid dose vaccine administration platform. This technology provides needle free vaccine delivery, which overcomes the fear of patients towards needle stick injuries. This award and recognition assisted the company to get recognized for its vaccine administration technology.
• In 2019, Gerresheimer AG launched a new glass innovation and technology centre in the U.S. As the company is engaged in manufacturing of glass syringes and needles for vaccine administration. This expansion assisted the company to improve the production of various vaccine administration devices.

Europe Vaccine administration devices Market Scope

The vaccine administration devices market is segmented on the basis of product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Syringes
• Auto Injectors
• Jet Injectors
• Micro Needles
• Inhalation/Pulmonary Delivery
• Microinjection System
• Pen Injector Devices
• Biodegradable Implants
• Electroporation-Based Needle Free Injection Systems
• Buccal /Sublingual Vaccine Delivery Systems
• Auto-Injector Trainer Devices
• Others Devices

Route of Administration

• Intramuscular
• Subcutaneous
• Intradermal

Type

• Marketed Vaccines
• Clinical-Stage Vaccines (Electroporation)

Brand

• BD Accuspray Nasal Spray System
• BD Hypak for Vaccines Glass Pre-Fillable Syringe System
• BD Uniject Auto-Disable Pre-Fillable Injection System
• Gx InnoSafe
• Gx RTF ClearJect, Plajex
• Others

Dosage

• Fixed
• Variable

Vaccine Type

• Bivalent Oral PolioVaccine
• BCG Vaccine
• Tetanus-Diphtheria Vaccine
• DTP-HEPB-HIB Vaccine
• Influenza Vaccine
• Pneumococcal Conjugate Vaccine
• Measles Vaccine
• Others

Modality

• Automatic Vaccine Administration Device
• Manual Vaccine Administration Device

Usability

• Disposable
• Reusable

End User

• Hospitals
• Community Centers
• Homecare Setting
• Research and Academic Institutes
• Ambulatory Surgical Center
• Others

 Distribution Channel

• Direct Tender
• Retail Sales

疫苗接种设备市场区域分析/见解

对疫苗接种设备市场进行了分析，并按上述产品、接种途径、类型、品牌、剂量、疫苗类型、方式、可用性、最终用户和分销渠道提供了市场规模洞察和趋势。

疫苗接种设备市场报告涉及的主要国家 是欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其和欧洲其他地区。

由于固定疫苗给药设备领域对疫苗给药设备的需求不断增长，预计德国将在预测期内实现最高复合年增长率。此外，全球多个政府都在增加疫苗接种支出，并在该地区展示了强大而有效的免疫计划领导力和所有权。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和欧洲疫苗接种设备市场份额分析

疫苗给药设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对疫苗给药设备市场的关注有关

疫苗接种设备市场的主要参与者包括：

• 美敦力（爱尔兰）
• Stening SRL（阿根廷）
• 库克（美国）
• 比卡克希拉尔医疗中心（伊斯坦布尔）
• TROGE MEDICAL GmbH（德国）
• 河南驼人医疗器械有限公司 (中国)
• Fisher & Paykel Healthcare Limited（新西兰）
• Medis Medical（英国）有限公司（英国）
• Pulmodyne, Inc.（美国）
• 富士系统（日本）
• DEAS SRL（意大利）
• Sterimed 集团 (印度)
• 康维特集团 (英国)
• Smiths Medical（英国）
• Andreas Fahl Medizintechnik – Vertrieb GmbH（德国）
• 波士顿医疗产品公司（美国）
• TRACOE medical GmbH（德国）
• Teleflex Incorporated（美国）
• 维利得医疗股份有限公司 (中国) 

SKU-55562